Insight Series

October 16, 2023 | 11:00 AM CT

This symposium will revisit the top abstracts from past Annual Meetings with presentations that cover post-meeting research and findings.  

Speakers

• Stefan Radtke, PhD - Fred Hutchinson Cancer Center
  Short- and Long-Term Hematopoietic Reconstitution After Transplantation is Stem Cell-driven and Stochastic: Implications for Gene Therapy 

• Peter Cook, PhD - Seattle Children's Hospital
  Generation of Islet-specific Engineered Regulatory T Cells (EngTregs) for Immune Tolerance Induction in Type 1 Diabetes Using a Novel Dual-editing Strategy

• Chang Li, PhD - University of Washington
  Correction of the Sickle Cell Mutation by In Vivo HSC Prime Editing in a Mouse Model

• Jenny Greig, PhD - Perelman School of Medicine, University of Pennsylvania
  AAV-Meganuclease-mediated Gene Targeting Achieves Efficient and Sustained
  Transduction in Newborn and Infant Macaque Liver

Watch on demand

More ASGCT Insights

Register for more sessions during ASGCT Insights Week, Oct. 16-20.

• Oct. 17: Risk Assessment of Lentiviral and AAV Gene Therapy Vectors

• Oct. 18: Risk Assessment for Gene Editing Technologies and Outcomes

• Oct. 19: Treating Genetic Diseases Prior to Birth from Stem Cells to Gene Delivery

• Oct. 20: Friend or Foe? Interplay Between Innate Immune Responses and Non-viral Gene Delivery